THYM
Thymalin
A peptide fraction extracted from calf thymus rather than a single synthetic molecule, which is the reason its identity is harder to pin down than the other entries in this category. What is supplied under the name is defined by its source tissue and extraction process; no receptor target has been established in the published literature.
No registered human study names Thymalin as an intervention. ClinicalTrials.gov holds no trial of it, so there is no trial evidence to read — a fact about the public record rather than proof the compound does nothing. No FDA-approved product contains Thymalin. 10 papers naming it were published in the last ten years.
Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Counts include only trials whose registered intervention names Thymalin; the registry search is fuzzy, so every match is re-checked. None of this says whether Thymalin works or is safe.
FDA status
Research only
Human studies
0
Furthest phase
—
Papers, 10 yr
10
Readership
—
Tracking since 2026-07-29 · About this data
What has actually been tested in humans
No registered human study
0
Registered human studies
None
No FDA-approved product contains it
No study of Thymalin in humans is registered on ClinicalTrials.gov. That is a fact about the public record, not a statement that the compound does nothing — but it does mean there is no trial evidence to read, and anyone telling you otherwise should be asked for the registration number. The grade is mechanical: it is computed from the registry and the FDA record alone, and it grades how much is known, never whether a compound is good or safe. Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Check the query.
What Thymalin is, and what it has been studied for
Thymalin is tracked here.
No registered trial names Thymalin as an intervention, so there is no condition it has been formally studied in. It does have a literature: 10 indexed papers name it in the last ten years. That work is laboratory and animal research, and a paper is not a trial.
Is anyone studying Thymalin?
Papers published each year that name Thymalin in the title or abstract, with the clinical trials that started in the same year marked beneath. Ten calendar years.
| Year | Publications | Trials started | Complete year |
|---|---|---|---|
| 2017 | 0 | 0 | Yes |
| 2018 | 1 | 0 | Yes |
| 2019 | 1 | 0 | Yes |
| 2020 | 2 | 0 | Yes |
| 2021 | 1 | 0 | Yes |
| 2022 | 2 | 0 | Yes |
| 2023 | 1 | 0 | Yes |
| 2024 | 2 | 0 | Yes |
| 2025 | 0 | 0 | Yes |
| 2026 | 0 | 0 | No |
10 papers between 2017 and 2026. A paper counts when “Thymalin” appears in its title or abstract — phrase-matched, so a paper mentioning the words separately is not counted. The total is a single query over the whole window, which is why it does not equal the bars added together: PubMed files a paper under both its electronic and its print publication date, so one paper can appear in two years. Publication volume measures scientific attention, not whether a compound works: a well-studied compound can be well-studied and ineffective. Sources: PubMed and ClinicalTrials.gov · collected 2026-08-02.
Published research on Thymalin
10 indexed papers name Thymalin in their title or abstract. These are the 8 PubMed ranks most relevant. Listing a paper is not a judgement about it, and none of these is summarised here — follow the link and read what it says.
- Peptides and Ageing
- Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells
- Geroprotective effect of thymalin and epithalamin
- The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19
- Reparative osteogenesis in mandible in cases of filling a bone defect with hydroxyapatite-containing osteotropic material and injecting the surrounding soft tissues with thymalin: experimental and morphological study
- Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo
- Expression features of T-lymphocytes, B-lymphocytes and macrophages in the post-traumatic regenerate of the mandible rats under conditions of filling a bone defect with hydroxyapatite-containing osteotropic material and thymalin injecting the surrounding soft tissues
- Thymalin in developing respiratory organs of human fetus
Collected 2026-08-02from PubMed, phrase-matched on “Thymalin” in title and abstract. Run the same search.
About Thymalin
A peptide fraction extracted from calf thymus rather than a single synthetic molecule, which is the reason its identity is harder to pin down than the other entries in this category. What is supplied under the name is defined by its source tissue and extraction process; no receptor target has been established in the published literature.
- Also known as
- Thymus extract
Structure and mechanism only. Nothing above describes what this compound is for, and no dose appears anywhere on this page.
Reading on this compound
All articles →PepRack articles that reference this compound. This is not a news feed — we syndicate nothing and publish no datelines.
Vendor listings are not affiliate links and PepRack earns nothing from them. A listing records a price we observed on a date. It is not a recommendation of a product, dose, or treatment, and PepRack does not verify what any vendor ships.